Combined epineurial therapy with neutralizing antibodies to tumor necrosis factor-alpha and interleukin-1 receptor has an additive effect in reducing neuropathic pain in mice.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples